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Trust, London WC1N 3JH, UKBackground & Aims: In the normal liver, hepatocytes form a
uniquely polarised cell layer that enables movement of solutes
from sinusoidal blood to canalicular bile. Whilst several chole-
Conclusions:Vps33b has a key role in establishing structural and
functional aspects of hepatocyte polarity and may be a target for
gene replacement therapy.static liver diseases with defects of hepatocyte polarity have been
identified, the molecular mechanisms of pathogenesis are not
well defined. One example is arthrogryposis, renal dysfunction
and cholestasis syndrome, which in most patients is caused by
VPS33B mutations. VPS33B is a protein involved in membrane
trafficking that interacts with RAB11A at recycling endosomes.
To understand the pathways that regulate hepatocyte polarity
better, we investigated VPS33B deficiency using a novel mouse
model with a liver-specific Vps33b deletion.
Methods: To assess functional polarity, plasma and bile samples
were collected from Vps33b liver knockout (Vps33bfl/fl-AlfpCre)
and control (Vps33bfl/fl) mice; bile components or injected sub-
strates were quantitated by mass spectrometry or fluorometry.
For structural analysis, livers underwent light and transmission
electron microscopy. Apical membrane and tight junction protein
localisation was assessed by immunostaining. Adeno-associated
virus vectors were used for in vivo gene rescue experiments.
Results: Like patients, Vps33bfl/fl-AlfpCre mice showed mislocali-
sation of ATP-binding cassette proteins that are specifically traf-
ficked to the apical membrane via Rab11a-positive recycling
endosomes. This was associated with retention of bile compo-
nents in blood. Loss of functional tight junction integrity and
depletion of apical microvilli were seen in knockout animals.
Gene transfer partially rescued these defects.Journal of Hepatology 20
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E-mail address: p.gissen@ucl.ac.uk (P. Gissen).Lay summary: Hepatocytes are liver cells with tops and bottoms;
that is, they are polarised. At their bottoms they absorb substances
from blood. They then, at their tops, secrete these substances and
their metabolites into bile. When polarity is lost, this directional
flow of substances from blood to bile is disrupted and liver disease
follows. In this study, using a new mouse model with a liver-
specific mutation of Vps33b, the mouse version of a gene that is
mutated in most patients with arthrogryposis, renal dysfunction
and cholestasis (ARC) syndrome, we investigated how the Vps33b
gene product contributes to establishing hepatocyte polarity. We
identified in these mice abnormalities similar to those in children
with ARC syndrome. Gene transfer could partly reverse the mouse
abnormalities. Our work contributes to the understanding of
VPS33B disease and hepatocyte polarity in general, and may point
towards gene transfer mediated treatment of ARC liver disease.
 2017 European Association for the Study of the Liver. Published
by Elsevier B.V. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/4.0/).Introduction
In metazoans, the development of three-dimensional body struc-
tures depends on the generation of polarised epithelial layers.
Polarisation of epithelial cells is a complex process that requires
the cooperation of multiple factors including cell junction forma-
tion, extracellular matrix interactions and intracellular protein
trafficking [1]. Correct interaction of these factors enables the
establishment of discrete apical and basolateral membrane
domains. This then promotes normal epithelial cell function by
allowing directional solute absorption and secretion [2].
In hepatocytes, the basolateral membrane faces sinusoidal
blood and one or more apical domains contribute to the17 vol. 66 j 1001–1011
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formation of bile canaliculi in conjunction with adjacent hepato-
cytes. This polarisation enables the directional flow of molecules
from sinusoidal blood to canalicular bile and, as such, is crucial
for normal biliary physiology [3]. Genetic disorders of hepatic
tight junction formation and protein trafficking entail a loss of
hepatocyte polarity. This impaired hepatocyte polarity causes
pathophysiological features similar to those of cholestatic liver
diseases caused by mutations in genes encoding apical ATP-
binding cassette transporters [4–7].
One such polarity-loss disorder is arthrogryposis renal dys-
function and cholestasis syndrome (ARC). ARC is an autosomal
recessive multisystem disorder. It has a spectrum of severity
and typically is characterised by congenital joint contractures,
renal tubular acidosis and neonatal jaundice leading to death in
infancy [8]. However, in milder cases patients survive into adult-
hood and have raised serum bile acid values but normal bilirubin
levels [9]. Approximately 75% of ARC patients harbour germline
mutations in VPS33B. VPS33B is orthologous to the yeast
Sec-1-Munc18 family protein Vps33p: a class C vacuolar protein
sorting (vps) protein that regulates SNARE-mediated vesicle
fusion [10]. Class C vps proteins are core constituents of the
homotypic fusion and vacuole protein sorting (HOPS) and class
C core vacuole/endosome tethering (CORVET) multiprotein com-
plexes, crucial in several stages of vesicular trafficking [11].
Whilst the Vps33p ortholog VPS33A is recognised as a member
of the mammalian HOPS complex [12], the function of VPS33B
is associated with the activity of Rab11 family members [13].
Rab11a is involved in protein trafficking via the apical recy-
cling endosome (ARE) and, thereby, biogenesis of the apical
membrane domain [14]. Canalicular proteins that are specifically
trafficked via Rab11a-positive ARE are mislocalised in ARC
patient liver [8,11]. Whilst patients’ serum aminotransferase
and gamma-glutamyl transpeptidase (cGT) activities are normal,
serum alkaline phosphatase (ALP) activity is substantially ele-
vated [8].
To treat the human liver diseases associatedwith failure to reg-
ulate apical-basolateral polarity, one must understand the path-
ways that govern hepatocyte polarisation. We therefore
investigated themolecular pathology of ARC liver disease to eluci-
date the role of VPS33B in establishing hepatocyte polarity in
mammals. We generated and characterised a novel murine model
with a liver-specificVps33b genemutation (Vps33bfl/fl-AlfpCre) that
recapitulates key aspects of ARC liver disease. In Vps33bfl/fl-AlfpCre
animals we observed structural and functional defects of hepato-
cyte polarity associated with failure to generate the canalicular
membrane correctly. We could, in part, reverse these defects by
adeno-associated virus mediated gene transfer.Materials and methods
Vps33bfl/fl-AlfpCre mouse generation
Mice with Vps33b exons 2–3 flanked by loxP sites were generated by Artemis
Pharmaceuticals (Cologne, Germany) as described and crossed onto a C57BL/6 J
background [15]. Mice were further crossed with AlfpCre-recombinase expressing
animals to obtain Vps33bfl/fl-AlfpCre mice with hepatocyte and cholangiocyte
specific Vps33b deletion [16]. Animals were sacrificed at 14–16 weeks of age
and Cre-negative, age matched littermates were used as wild-type controls. For
experiments on a cholic acid (CA) diet, 8 week old mice were fed 0.5% CA supple-
mented chow (TestDiet Europe, London, UK) for 6 weeks and sacrificed immedi-
ately thereafter at age 14 weeks. For histologic assessment in older animals, mice
were aged for 10 to 12 months and fed a normal chow diet. All experimental1002 Journal of Hepatology 2017animal groups were of mixed gender. All procedures were undertaken with Uni-
ted Kingdom Home Office approval in accordance with the Animals (Scientific
Procedures) Act of 1986.
Mass spectrometry
Bile acids were quantified by UPLC-MS/MS [17]. Bile acid concentrations in bile
were corrected by flow rate. Details are provided in the Supplementary methods
section.
Transmission electron microscopy (TEM)
Details of TEM procedures [13] are provided in the Supplementary methods
section.
Biliary secretion analysis
For analysis of bile composition, bile was collected by cannulating the gall blad-
der of 14–16-week-old CA fed mice using polyethylene (PE-10) tubing following
midline laparotomy and ligation of the common bile duct. Analysis of biliary
cholyl-L-lysyl-fluorescein (CLF) secretion via MRP2 was carried out using
in vivomethods [18]. Integrity of hepatic tight junction barrier function was mea-
sured using 40 kDa fluorescein isothiocyanate (FITC)-conjugated dextran (FD-40)
[19]. Results obtained from CLF and FD-40 fluorometric analysis were corrected
for bile flow rate.
Microarray analysis
Total RNA was extracted from liver samples using the RNAeasy Microkit per man-
ufacturer’s instructions (Qiagen, Manchester, UK). RNA transcript levels were
measured using Affymetrix Mouse Gene 2.0 microarrays. Details of in silico gene
expression and pathway analysis are described in the Supplemental methods
section.
The data discussed in this publication have been deposited in NCBI’s Gene
Expression Omnibus [20] and are accessible through GEO series accession num-
ber GSE83192 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE83192).
Adeno-associated virus (AAV) vector production
All ssAAV2/8 vectors were made by the adenovirus-free transient transfection
method, using a chimeric AAV2 Rep-8Cap packaging plasmid (pAAV2-8) and an
adenoviral helper plasmid [21]. Vectors were purified [22] and vector genome
(vg) titres were determined by standard alkaline gel based methods [23]. Details
of molecular cloning procedures are provided in the Supplemental methods
section.
Serum and bile biochemical assays, immunoblotting and histological and
immunostaining
All the above procedures are described in the Supplemental methods section.Results
The ARC liver phenotype is recapitulated in Vps33bfl/fl-AlfpCre mice
and exacerbated by CA feeding
Loss of Vps33b expression in hepatocytes of Vps33bfl/fl-AlfpCre
animals was confirmed by fluorescence in situ hybridisation and
Western blotting techniques (Supplementary Fig. 1A and B).
To assess hepatobiliary injury associated with Vps33b muta-
tion, levels of plasma ALP activity; alanine aminotransferase
(ALT) activity and bilirubin concentrations were measured in 14-
week-old animals fed normal chow or a 0.5% CA diet (n = 4–6).
As in ARC patients, a significant increase in plasma ALP activity
was detected in normal chow fed Vps33bfl/fl-AlfpCre mice (3-fold,vol. 66 j 1001–1011
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Fig. 1. ARC liver disease in Vps33bfl/fl-AlfpCre mice. (A) Plasma ALP activity, (B) plasma ALT activity (C) liver mass and (D) total plasma bile acid levels assessed in 14-
week-old normal chow fed and cholic acid (CA) fed Vps33bfl/fl-AlfpCre and Vps33bfl/fl mice (n = 4–6). (E) Trichrome staining of liver sections from 14-week-old CA fed mice
and 12-month-old mice fed with normal diet (n = 3). Graphs are presented with medians and IQR. p values (Mann Whitney U test): ALP activity, p = 0.0317 and p = 0.0022;
ALT activity p = 0.0591 and p = 0.1775; plasma bile acids, p = 0.0043 and p = 0.0022; liver mass, p = 0.0117 and p = 0.0050 (normal chow fed and CA fed comparisons
respectively).
JOURNAL OF HEPATOLOGYmedian: 241.0 U/L, IQR: 123.5–283.5 U/L) in comparison to Cre-
negative Vps33bfl/fl littermates (median: 80.0 U/L, IQR: 54.0–
113.50 U/L) (Fig. 1A, p = 0.0317, Mann Whitney U test). In CA fed
animals, a greater increase in ALP activity (6.5-fold) was observed
in the plasma of Vps33bfl/fl-AlfpCre mice (median: 874.5 U/L, IQR:
688.0–994.5 U/L) than in that of Vps33bfl/fl mice (median: 134.0 U/
L, IQR: 108–144.0 U/L) (Fig. 1A, p = 0.0022, MannWhitney U test).
Whilst ALT activity levels appeared slightly raised in
Vps33bfl/fl-AlfpCre animals, no significant difference in plasma
ALT activity was found between Vps33bfl/fl and Vps33bfl/fl-AlfpCre
mice under both diet conditions (Fig. 1B, normal diet p = 0.0591,
CA diet p = 0.1775, Mann Whitney U test). Although ALT activity
levels increased in both Vps33bfl/fl and Vps33bfl/fl-AlfpCre animals
following CA feeding, this increase was not statistically significant
(Vps33bfl/fl p = 0.0691, Vps33bfl/fl-AlfpCre p = 0.1111). Addition of
CA to the diet may therefore have a slight effect on liver injury
in both wild-type and knockout animals. CA feeding consistently
increased liver mass in Vps33bfl/fl and Vps33bfl/fl-AlfpCre mice
(1.5-fold, Vps33bfl/fl p = 0.0078, Vps33bfl/fl-AlfpCre p = 0.0043) and
liver mass was significantly increased between Vps33bfl/fl and
Vps33bfl/fl-AlfpCre mice under both diet conditions (normal diet
1.7-fold; p = 0.0117, CA diet 1.5-fold; p = 0.0050) (Fig. 1C). Plasma
bilirubin concentrationswere belowdetection level (<2 lmol/L) in
all experimental groups.
As high plasma bile acid levels characterise ARC cholestasis
[8], we measured bile acids in mouse plasma by massJournal of Hepatology 2017spectrometry (n = 5–6). Concordantly, median total bile acid
levels of 97.30 lM (IQR: 68.85–259.2 lM) and 12.65 lM (IQR:
7.65–20.90 lM) were observed in normal diet Vps33bfl/fl-AlfpCre
and Vps33bfl/fl samples respectively (Fig. 1D, 7.6-fold, p = 0.0043,
Mann Whitney U test). In CA diet Vps33bfl/fl-AlfpCre and
Vps33bfl/fl plasma samples, total bile acid levels were increased
with respective concentrations of 190.4 lM (IQR: 78.2–
295.9 lM) and 24.1 lM (IQR: 13.0–31.9 lM) detected (7.9-fold,
p = 0.0022).
These results collectively show that key biomarkers of ARC
cholestasis (raised plasma ALP and bile acid levels, with normal
aminotransferase levels) are recapitulated in Vps33bfl/fl-AlfpCre
mice fed either normal chow or a 0.5% CA diet. As CA feeding
did not create artefactual phenotypes in Vps33bfl/fl-AlfpCre mice
and only exacerbated disease phenotypes already observed at
physiological level, CA feeding was not considered a confounding
factor. The remaining experiments in this study were carried out
in CA fed animals unless otherwise stated.
Histologic findings in livers of Vps33bfl/fl-AlfpCre mice
Light microscopy of 14-week-old, CA fed Vps33bfl/fl-AlfpCre
mouse liver sections primarily revealed fibrotic changes that
were not observed in Vps33bfl/fl sections. By trichrome staining
(n = 3) we observed periportal and pericentral fibrous expansion
with focal bridging fibrosis in Vps33bfl/fl-AlfpCre mice (Fig. 1E). Asvol. 66 j 1001–1011 1003
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Fig. 2. Functional polarity defects in Vps33bfl/fl-AlfpCre mice. (A) Immunostaining for detection of BSEP and (B) MRP2 localisation in Vps33bfl/fl-AlfpCre and Vps33bfl/fl
liver sections. (C) Plasma and bile levels of cholesterol and (D) phospholipid in Vps33bfl/fl-AlfpCre and Vps33bfl/fl mice assessed by fluorometric analysis (n = 5, p = 0.0079 in
all tests, Mann Whitney U test). (E) Cumulative biliary levels of CLF and (F) blood levels of CLF measured in Vps33bfl/fl-AlfpCre and Vps33bfl/fl (n = 4). All mice were fed a
cholic acid supplemented diet and sacrificed at 14–15 weeks of age. Graphs are presented with medians and IQR.
Research Articleleucocyte infiltration was observed in Vps33bfl/fl-AlfpCre liver
(Supplementary Fig. 2), these fibrotic changes may indicate a
response to inflammation caused by cholestasis in Vps33bfl/fl-
AlfpCre animals.
Trichrome staining of liver sections from 12-month-old
Vps33bfl/fl-AlfpCre mice fed normal chow revealed marked geo-
graphic fibrosis and focal steatosis (n = 3) (Fig. 1E). This suggests
a progression of fibrotic changes and possible defects of lipid
metabolism and accumulation in aged animals.
To investigate the mechanism of liver damage in Vps33bfl/fl-
AlfpCre mice, levels of apoptosis were assessed by immunostain-
ing 14-week-old liver sections to detect cleaved caspase 3 (CC3)
protein (n = 3). The percentage of CC3 positive cells per field of
view was significantly increased in Vps33bfl/fl-AlfpCre sections
in comparison to Vps33bfl/fl sections under both normal diet and
CA diet conditions (p <0.0001 and p = 0.0058 respectively, Mann
Whitney U test) (Supplementary Fig. 3). This suggests that
apoptosis may contribute to the liver injury observed in
Vps33bfl/fl-AlfpCre mice. However, in comparison to cholestatic
mouse models of bile salt export pump (BSEP) deficiency, the per-
centage of apoptotic cells detected in Vps33bfl/fl-AlfpCre sections
was relatively low [24].
Vps33bfl/fl-AlfpCre animals show mislocalisation of apical membrane
proteins
In vitro studies have suggested that VPS33B has a role in apical
membrane protein trafficking in epithelial cells [11]. This is
reported specifically to involve interaction with Rab11a-positive1004 Journal of Hepatology 2017ARE. To investigate possible defects of protein trafficking to the
canalicular membrane, we used immunostaining of Vps33bfl/fl
and Vps33bfl/fl-AlfpCre mouse liver sections to assess the localisa-
tion of apical membrane proteins known to be trafficked via
Rab11a-positive ARE (n = 3). In contrast to Vps33bfl/fl tissue, in
Vps33bfl/fl-AlfpCre sections we observed absence of the ATP-
binding cassette proteins BSEP and ABCG8 at the hepatocyte
canalicular membrane (Fig. 2A and Supplementary Fig. 4A). These
proteins are responsible for secretion into bile of conjugated bile
acids and cholesterol respectively [25–27]. We also observed
mislocalisation of the GPI anchored glycoprotein carcinoembry-
onic antigen (CEA) in Vps33bfl/fl-AlfpCre liver with a diffuse stain
appearing around the entire hepatocyte membrane as opposed to
the clear and selective apical marking in Vps33bfl/fl liver (Supple-
mentary Fig. 4B). Multidrug resistance-associated protein 2
(MRP2) reportedly bypasses the RE during apical trafficking
[28,29]. Interestingly, as in ARC patients, MRP2 did not appear
mislocalised in Vps33bfl/fl-AlfpCre mouse liver (Fig. 2B). Localisa-
tion of basolateral proteins appeared unaffected by loss of Vps33b
(Supplementary Fig. 4C).
Immunofluorescence detection of BSEP in normal chow fed
mice established that protein mislocalisation was not an artefact
of CA feeding and also showed intracellular punctate staining in
Vps33bfl/fl-AlfpCre sections (Supplementary Fig. 5A).
Immunoblotting analysis showed that BSEP and ABCG8 expres-
sion levels were not strongly affected in Vps33bfl/fl-AlfpCre liver
(Supplementary Fig. 5B and C). These data collectively suggest
that canalicular proteins were mislocalised to intracellular vesi-
cles rather than downregulated in Vps33bfl/fl-AlfpCre liver.vol. 66 j 1001–1011
Table 1. Concentrations of bile acids in plasma from Vps33bfl/fl and Vps33bfl/fl-AlfpCre mice fed 0.5% cholic acid.
Bile acid Vps33bfl/fl Vps33bfl/fl-AlfpCre Comparison
Median, lM 25th Percentile 75th Percentile Median, lM 25th Percentile 75th Percentile p value
(Mann Whitney U)
TCA 1.99 (9.69%) 1.49 4.16 97.9 (54.55%) 46.2 183 0.002
GCA 1.09 (5.31%) 0.57 1.61 10.6 (5.91%) 6.99 24.4 0.002
CA 3.44 (16.75%) 2.19 5.84 24.2 (13.48%) 5.50 33.0 0.02
Tauro-diOH-C 1.98 (9.64%) 1.28 2.62 14.8 (8.25%) 5.67 25.4 0.004
Glyco-diOH-C 0.08 (0.39%) 0.038 0.15 0.74 (0.41%) 0.20 2.30 0.002
DiOH-C 11.8 (57.45%) 5.41 19.9 24.0 (13.37%) 11.8 33.4 0.13 (ns)
Tauro-tetraOH-C 0.08 (0.39%) 0.068 0.16 6.40 (3.57%) 1.77 10.8 0.0048
Glyco-tetraOH-C 0.03 (0.15%) 0.018 0.057 0.78 (0.43%) 0.64 2.68 0.0238
TetraOH-C 0.05 (0.23%) 0.03 0.058 0.06 (0.03%) 0.03 0.09 0.5097 (n.s.)
Contributions of individual bile acids to the total bile acid pool are listed as percentages in parenthesis.
CA, cholic acid; C, cholanoate; T, tauro; G, glyco; DiOH, dihydroxy; tetra-OH, tetrahydroxy.
JOURNAL OF HEPATOLOGYDisruption of functional hepatocyte polarity in Vps33bfl/fl-AlfpCre
mice
To investigate the physiological impact of apical protein mislo-
calisation, levels of bile components were assessed by mass spec-
trometry in plasma and bile samples of CA fed Vps33bfl/fl and
Vps33bfl/fl-AlfpCre mice (n = 4–6). We observed a significant
increase in plasma bile salt levels of Vps33bfl/fl-AlfpCre animals
over those of Vps33bfl/fl mice (Table 1). The major accumulating
bile acid in plasma was taurocholate, which in Vps33bfl/fl-
AlfpCre mice was present at a median concentration of
97.9 lM: 49-fold higher than the median concentration in
Vps33bfl/fl mice. The median concentrations of most other bile
acid species were also increased: glycocholate 9.7-fold; cholate
7-fold; tauro-diOH-cholanoates 7.5-fold; glyco-diOH-
cholanoates 9.3-fold; tauro-tetraOH-cholanoates 80-fold; glyco-
tetraOH-cholanoates 26-fold.
In comparison to Vps33bfl/fl mice, the main biliary bile acid,
taurocholate, was present at 1.9-fold higher concentrations in
Vps33bfl/fl-AlfpCre mouse bile (not statistically significant). Bil-
iary levels of glyco-diOH-cholanoates were equivalent between
Vps33bfl/fl-AlfpCre and Vps33bfl/fl animals (Table 2). However,
median biliary concentrations of all other bile acids were lower
in Vps33bfl/fl-AlfpCre mice than in Vps33bfl/fl mice (1.9-, 13.3-,
1.5- and 4.3-fold reduction in glycocholate, unconjugated cho-
late, tauro-diOH-cholanoates, and unconjugated diOH-
cholanoates respectively). These reduced concentrations were
not statistically significant excepting unconjugated cholate
(p = 0.0190).
Total cholesterol and phospholipid levels were also signifi-
cantly increased in plasma (2.8- and 2-fold respectively) and
decreased in bile (3.6- and 1.5-fold respectively) of Vps33bfl/fl-
AlfpCre animals (p = 0.0079 in all tests, Mann Whitney U test)
(Fig. 2C and D). Collectively these results suggest that the direc-
tional flow of bile components from blood to canalicular bile is
disrupted in Vps33bfl/fl-AlfpCre mice. Increased levels of plasma
total cholesterol were confirmed in normal chow fed Vps33bfl/fl-
AlfpCre (Supplementary Fig. 6A).
In a further group of 14-week-old CA fed animals, we analysed
the composition of plasma cholesterol as concentrations of total
(Supplementary Fig. 6B), free and esterified cholesterol (n = 6–
7). Levels of free cholesterol in plasma of Vps33bfl/fl-AlfpCre mice
were significantly increased (3.6-fold; p = 0.0012, Mann Whitney
U test) over those of Vps33bfl/fl animals (Supplementary Fig. 6C,Journal of Hepatology 2017median: 0.3678 lg/ll; IQR: 0.2996–0.5072 lg/ll and median:
0.1036 lg/ll; IQR: 0.0836–0.1615 lg/ll respectively) whilst
levels of esterified cholesterol were equivalent between
Vps33bfl/fl-AlfpCre and Vps33bfl/fl mice (Supplementary Fig. 6D,
median: 0.5134 lg/ll; IQR: 0.3869–0.5459 lg/ll and median:
0.4371 lg/ll; IQR: 0.3998–0.5747 lg/ll respectively). This sug-
gests that the increased levels of total cholesterol observed in
plasma of Vps33bfl/fl-AlfpCre mice are largely due to the increase
in concentration of free cholesterol as opposed to esterified
cholesterol.
CLF is secreted into canalicular bile specifically via MRP2 [18].
To determine whether MRP2 protein was functional as well as
correctly localised in Vps33bfl/fl-AlfpCre hepatocytes, anaes-
thetised animals were given an intravenous injection of CLF fol-
lowed by collection of bile and plasma fractions for
fluorometric quantification of CLF (n = 4). Plasma and bile levels
of CLF did not significantly differ between Vps33bfl/fl-AlfpCre
and Vps33bfl/fl mice, suggesting normal MRP2 function in Vps33b
deficiency (Fig. 2E and F). However, accumulation of CLF in bile
appeared more rapid in Vps33bfl/fl-AlfpCre animals. This is consis-
tent with reports that suggest an increase in mouse MRP2 expres-
sion levels in liver in response to bile acid retention [30].
Inflammatory and metabolic pathways are perturbed in Vps33bfl/fl-
AlfpCre liver
To assess differential gene expression in liver following Vps33b
deletion, we carried out microarray analysis of total RNA isolated
from Vps33bfl/fl and Vps33bfl/fl-AlfpCre liver samples (n = 4–6)
from mice fed a 0.5% CA diet and sacrificed at 10–14 weeks.
Using partial least squares (PLS) regression, we observed that
the first PLS component clearly separated Vps33bfl/fl-AlfpCre from
Vps33bfl/fl liver samples (Supplementary Fig. 7). Relevant genes
were identified by selecting those with the largest contribution
to the first component (Fig. 3).
In comparison to samples from Cre-negative littermates, in
Vps33bfl/fl-AlfpCre liver, we observed upregulation of several
genes involved in the inflammatory response. This included
markers of immune cells (Ly6d, Cd14) as well as chemokines that
induce immune cell infiltration (Ccl2, Cxcl10). Using the Database
for Annotation, Visualization and Integrated Discovery (DAVID),
we identified many over-represented gene ontology annotations
in the top 150 genes (Supplementary Fig. 8). In particular, we
observed terms relating to ‘inflammatory response’ but annota-vol. 66 j 1001–1011 1005
Table 2. Concentrations of bile acids in bile from Vps33bfl/fl and Vps33bfl/fl-AlfpCre mice fed 0.5% cholic acid corrected by flow rate.
Bile acid Vps33bfl/fl Vps33bfl/fl-AlfpCre Comparison
Median (nmol/
min.100 g)
25th
Percentile
75th
Percentile
Median (nmol/
min.100 g)
25th
Percentile
75th
Percentile
p value
(Mann Whitney
U)
TCA 47.26 (68.48%) 33.76 53.74 90.42 (92.26%) 70.67 99.24 0.0667(n.s.)
GCA 2.93 (4.25%) 2.12 3.99 1.58 (1.61%) 0.98 2.88 0.2571 (n.s.)
CA 11.21 (16.24%) 7.28 11.60 0.84 (0.86%) 0.14 4.55 0.0190
Tauro-
diOH-C
7.30 (10.58%) 4.96 8.41 4.93 (5.03%) 2.74 6.23 0.0667(n.s.)
Glyco-
diOH-C
0.18 (0.26%) 0.15 0.21 0.21 (0.21%) 0.19 0.27 0.1714 (n.s.)
DiOH-C 0.13 (0.19%) 0.08 0.31 0.03 (0.03%) 0.00 0.08 0.1143(n.s.)
Contributions of individual bile acids to the total bile acid pool are listed as percentages in parenthesis.
CA, cholic acid; C, cholanoate; T, tauro; G, glyco; DiOH, dihydroxy; tetra-OH, tetrahydroxy.
Research Articletions such as ‘membrane’ and ‘extracellular region’ were also
elicited.
Additionally, numerous genes involved in metabolic pathways
were identified as misregulated in Vps33bfl/fl-AlfpCre mouse liver.
Gene set enrichment analysis consistently identified the Kegg
pathway bile acid biosynthesis as the most perturbed pathway
in Vps33bfl/fl-AlfpCre animals. Several other metabolic and
inflammatory pathways also were perturbed (Supplementary
Table 1).
Collectively, these data support our observations of inflamma-
tion and fibrotic changes in Vps33bfl/fl-AlfpCre liver and suggests
that intrahepatic retention of bile components may directly
result in dysregulation of bile acid metabolism in Vps33bfl/fl-
AlfpCre mice.
The hepatocyte phenotype is rescued by AAV mediated gene transfer
To determine whether reintroduction of VPS33B to Vps33bfl/fl-
AlfpCre hepatocytes could restore structural and functional
polarity, we performed gene transfer experiments using
ssAAV2/8 vectors containing either wild-type or codon optimised
human VPS33B cDNA (ssAAV2/8-EFS-hVPS33B-WPRE and
ssAAV2/8-EFS-hVPS33Bco-WPRE respectively) (Fig. 4A). Vectors
were administered to 5-week-old mice at a dose of 1  1012 vec-
tor genomes (vg) per animal via intraperitoneal injection. At
8 weeks of age, injected animals and control groups received CA
supplemented feed for 6 weeks. At 14 weeks, without re-
exposure to a normal diet, animals were sacrificed and transgene
expression in hepatocytes was confirmed immunohistochemi-
cally (Supplementary Fig. 9).
In animals treated with ssAAV2/8-EFS-hVPS33B-WPRE and
ssAAV2/8-EFS-hVPS33Bco-WPRE vectors, we observed respective
2.1- and 4.9-fold decreases in median levels of plasma ALP vs.
Vps33bfl/fl-AlfpCre mice (Fig. 4B). This was accompanied by a
2.7-fold decrease of total plasma bile acid levels in ssAAV2/8-
EFS-hVPS33B-WPRE treated mice and a significant 11-fold
decrease in plasma bile acid levels of mice receiving ssAAV2/8-
EFS-hVPS33Bco-WPRE (p = 0.0015, Kruskal-Wallis test) (Fig. 4C).
Plasma levels of cholesterol and phospholipid were also reduced
in mice receiving ssAAV2/8-EFS-hVPS33B-WPRE and ssAAV2/8-
EFS-hVPS33Bco-WPRE vectors (Fig. 4D and E).
Immunostaining demonstrated partial restoration of canalicu-
lar membrane protein localisation following gene transfer with
both vectors (Fig. 4F; Supplementary Fig. 10). This suggests that,1006 Journal of Hepatology 2017following gene transfer, functional polarity is rescued, as mani-
fest by correction of protein localisation to the apical membrane.
Vps33bfl/fl-AlfpCre hepatocytes show tight junction defects
Hepatic tight junctions constitute the barrier that separates sinu-
soidal blood from canalicular bile. Following knockdown of
Rab11a, WIF-B9 cells form tight junctions that appear morpho-
logically abnormal [31]. To study the role of Vps33b in Rab11a
dependent canalicular membrane biogenesis, we investigated
tight junction abnormalities in Vps33bfl/fl-AlfpCre liver by
immunostaining for Claudin1. In control Vps33bfl/fl liver, Claudin1
staining revealed normal belt-like tight junctions (Fig. 5A). In
Vps33bfl/fl-AlfpCre tissue, Claudin1 marking was irregular and tor-
tuous, suggesting changes in tight junction organisation (Fig. 5B).
Following gene transfer of 1 x 1012 vg/animal ssAAV2/8-EFS-
hVPS33Bco-WPRE vector, we observed partial correction of tight
junction appearance (Fig. 5C).
To assess functional integrity of hepatic tight junctions in
Vps33bfl/fl-AlfpCre and Vps33bfl/fl liver, we measured levels of
FD-40 in bile following intravenous injection. Disruption of tight
junction barrier function results in rapid biliary accumulation of
FD-40. Fluorometry documented build-up of FD-40 in the bile of
Vps33bfl/fl-AlfpCre mice earlier than in control Vps33bfl/fl litter-
mates (p = 0.01342) (Fig. 5D). This observation suggests that tight
junctions in Vps33bfl/fl-AlfpCre mice, abnormal in Claudin1 distri-
bution on immunostaining, were defective in function.
Structural abnormalities of Vps33bfl/fl-AlfpCre canaliculi
Ultrastructure of Vps33bfl/fl-AlfpCre and Vps33bfl/fl canaliculi was
assessed by TEM. Relative to Cre-negative littermates, we
observed a marked paucity of canalicular microvilli in
Vps33bfl/fl-AlfpCre hepatocytes (Fig. 6A and B). Ultrastructure of
the bile canaliculi appeared restored in mice treated with
ssAAV2/8-EFS-hVPS33Bco-WPRE vector (Fig. 6C). To quantify
these observations in terms of apical membrane length relative
to canaliculus size, we measured the total inner membrane
length of the bile canaliculi and normalised these values to the
length of the outer canalicular perimeter (Fig. 6D). In
Vps33bfl/fl-AlfpCre cells we observed a significant decrease in
inner membrane length in comparison to Vps33bfl/fl cells. This
corresponds to an overall loss of canalicular membrane surface
area in the absence of Vps33b. This observation was accompaniedvol. 66 j 1001–1011
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JOURNAL OF HEPATOLOGYby a significant increase in canalicular membrane length in hep-
atocytes of AAV treated mice in comparison to untreated Vps33bfl/
fl-AlfpCre animals (p <0.001, One way ANOVA, Bonferroni’s test).
Measurements of tight junction length and breadth did not differ
between Vps33bfl/fl and Vps33bfl/fl-AlfpCre micrographs (Supple-
mentary Fig. 11).Discussion
Loss of apical-basolateral hepatocyte polarity is observed in many
types of inherited cholestatic liver disease and in liver cancer
[4–7,32,33]. However, the molecular mechanisms that cause this
loss are not well determined. In this study, we aimed to improve
understanding of the pathways that govern hepatocyte polarity.
Specifically, we investigated the role of VPS33B in biogenesis of
the bile canaliculus and subsequent maintenance of apical
domain structure and function. To achieve this aim, we generated
a novel murine model with a liver epithelial cell-specific deletion
of Vps33b (Vps33bfl/fl-AlfpCre) that recapitulates hepatocyte polar-
ity defects observed in patients with ARC syndrome.
ARC patients with VPS33B mutations show cholestasis with
high plasma ALP activity and bile acid levels. Patients’ amino-
transferase activity and cGT levels remain normal [8]. In agree-
ment with these data, our Vps33bfl/fl-AlfpCre mice demonstrated
significant increases in plasma ALP and total bile acid levels in
comparison to Cre-negative littermates. As seen in otherJournal of Hepatology 2017cholestasis models, these phenotypes were exacerbated by CA
feeding [34]. No significant difference in plasma ALT activity
was observed in Vps33bfl/fl-AlfpCre vs. Vps33bfl/fl mice and cGT
levels were not assessed as mice do not express cGT in hepato-
cytes after birth [35]. Biomarkers in our Vps33bfl/fl-AlfpCre mouse
thus accurately track those used to assess ARC liver disease. Like
patients with clinically milder ARC, Vps33bfl/fl-AlfpCre animals
did not manifest increased serum bilirubin levels.
As ALP is normally expressed at the apical hepatocyte mem-
brane, the increase in plasma ALP levels in Vps33bfl/fl-AlfpCre ani-
mals may be due to defects in apical membrane biosynthesis.
Further increases in plasma ALP caused by the CA diet may be
related to canalicular damage, although increased ALP synthesis
or shifts in localisation are also possible. Further evidence of
canalicular injury is supplied by immunostaining of ARC patient
liver biopsy specimens, which reveals mislocalisation of proteins
typically located at the apical membrane. Among these is BSEP,
an ATP-binding cassette transporter required for movement of
conjugated bile acids from blood to bile [25]. The mislocalisation
of BSEP was reproduced in our Vps33bfl/fl-AlfpCre animals under
both normal diet and CA diet conditions. By immunofluorescence,
we observed punctate intracellular BSEP staining, consistent with
localisation of BSEP in intracellular vesicles.
In patients with progressive familial intrahepatic cholestasis
type 2 (PFIC2), the loss of BSEP results in intrahepatic retention
of bile salts [36]. In the Bsep knockout mouse, severe cholestatic
liver disease is observed when mice are fed a diet containing 0.5%vol. 66 j 1001–1011 1007
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Research ArticleCA [24]. In agreement with these observations, by utilising a
recently developed mass spectrometry technique, we detected
significant increases (7 to 80-fold) in plasma concentrations of
TCA, GCA, CA, tauro-diOH-cholanoates, glyco-diOH-cholanoates,
tauro-tetra-OH-cholanoates and glyco-tetra-OH-cholanoates in
Vps33bfl/fl-AlfpCre mice fed 0.5% CA. Concentrations of plasma1008 Journal of Hepatology 2017bile acids in Vps33bfl/fl-AlfpCre animals were only slightly lower
than values previously observed in the Bsep knockout mouse [24].
Our comparison of biliary bile acid concentrations inVps33bfl/fl-
AlfpCre and Vps33bfl/fl mice also yielded results similar to those
obtained on comparison of Bsep knockout and wild-type mice
[24]. Neither the concentration of the major biliary bile acid com-vol. 66 j 1001–1011
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JOURNAL OF HEPATOLOGYponent, taurocholate, nor the total biliary bile acid concentration
differed significantly between Vps33bfl/fl-AlfpCre and Vps33bfl/fl
animals. This may indicate an alternative route of apical bile acid
secretion following CA feeding such as via MRP2 [37]. For some
of the lesser bile acids, biliary concentrations were lower in
Vps33bfl/fl-AlfpCre mice than in Vps33bfl/fl mice. This reduction in
biliary concentration was statistically significant only in the case
of unconjugated cholate. As in the Bsep knockout mouse, this
may indicate a higher rate of taurine conjugation and conversion
to tetra-OH bile acid species in Vps33bfl/fl-AlfpCre animals as a
mechanism of reducing bile acid toxicity [38]. Indeed, the propor-
tion of unconjugated bile acids in plasma and bile of Vps33bfl/fl-
AlfpCre mice was lower than that of Vps33bfl/fl littermates and a
significant increase in conjugated tetra-OH species was observed
in Vps33bfl/fl-AlfpCre plasma. Overall, these data suggest that mis-
localisation of BSEP in Vps33bfl/fl-AlfpCre mice has a similar effect
on transport of bile acids to the effect of Bsep knockout. However,
evenCA fedVps33bfl/fl-AlfpCre animals had normal serumbilirubin
concentrations, no obvious reduction in survival and only a small
increase in apoptosis (as detectedbyCC3 staining), thus suggesting
liver disease less severe than that in Bsep knockout mice [24].
In addition to BSEP mislocalisation, in Vps33bfl/fl-AlfpCre
hepatocytes we observed mislocalisation of ABCG8, an apical
ATP-binding cassette transporter involved in the directional
movement of cholesterol [27]. Concordant with a loss of apical
ABCG8, in comparison to Vps33bfl/fl mice, we detected reduced
levels of total cholesterol in bile and accumulation of cholesterol
in plasma of CA fed Vps33bfl/fl-AlfpCre animals. Collectively these
results suggest that, in the absence of Vps33b, apical transporter
proteins are mislocalised, causing an overall loss of functional
polarity and accumulation of bile components in blood.
Interestingly, the increase in plasma total cholesterol
observed in Vps33bfl/fl-AlfpCre animals was due to an increase
in free cholesterol as opposed to esterified cholesterol. In combi-
nation with our observation of canalicular proteins mislocalised
to possible intracellular vesicles, as in other cholestatic models,
this increase in free cholesterol may imply that the majority of
phospholipid and cholesterol in Vps33bfl/fl-AlfpCre plasma is pre-
sent in the form of lipoprotein X, biliary lipid vesicles that contain
mostly free cholesterol and phosphatidylcholine, ascribed in
cholestasis to shedding of hepatocyte membranes into bile and
thence, with bile, between hepatocytes into plasma [39,40].
Proteins that appear mislocalised in Vps33bfl/fl-AlfpCre mouse
hepatocytes are thought to be trafficked to the canalicular mem-Journal of Hepatology 2017brane specifically via Rab11a-positive ARE [41]. In our model we
observed mislocalisation of apical proteins that are trafficked
directly from the trans golgi network (TGN) to the ARE (BSEP
and ABCG8) as well as proteins that are first delivered to the
basolateral membrane from TGN and then transcytosed to the
canalicular membrane via ARE (CEA) [41]. However, as in ARC
patients, MRP2 was not mislocalised in Vps33bfl/fl-AlfpCre liver.
MRP2 is reported to bypass Rab11a-positive recycling ARE en
route to the hepatocyte apical domain [28,29]. Functional integ-
rity of MRP2 in Vps33bfl/fl-AlfpCre liver was confirmed by intra-
venous administration and subsequent quantification in bile of
cholyl-lysyl-fluorescein (a compound specifically exported into
bile via MRP2) [18]. As in zebrafish, these results suggest that
mammalian VPS33B is specifically involved in trafficking of pro-
teins to the apical domain via Rab11a-positive ARE [11].
Basolateral membrane proteins were not mislocalised in
Vps33bfl/fl-AlfpCre hepatocytes, suggesting a specific role for
VPS33B in biogenesis of the bile canaliculus.
As we observed in mutant mice that MRP2 is functional and
normally sited, as is MRP2 in ARC patients [11], we infer that
the collections of Dubin-Johnson-like pigment in some ARC
patients’ hepatocytes [42] are unlikely to originate from
MRP2 absence or dysfunction.
To assess defects in structural components of hepatocyte
polarity, we analysed tight junction integrity in Vps33bfl/fl-
AlfpCre and Vps33bfl/fl liver. As in cultured cells, immunohisto-
chemical marking for Claudin1, a tight junction component,
was irregular in Vps33bfl/fl-AlfpCre liver, with tortuous distribu-
tion [31]. Tight junctions between control Vps33bfl/fl hepatocytes
appeared uniform and belt-like. This suggestion of a structural
tight junction defect was supported by our functional analysis
of tight junction integrity which showed rapid accumulation of
fluorescence in the bile of Vps33bfl/fl-AlfpCre mice following intra-
venous injection of 40 kDa fluorescent dextran (FD-40). The
observed leaking of FD-40 from blood into bile suggests a loss
of tight junction barrier function in Vps33bfl/fl-AlfpCre hepato-
cytes [19]. Whether tight junction proteins are normally traf-
ficked to the apical membrane by VPS33B or loss of tight
junction integrity is a secondary effect of incorrect apical protein
trafficking remains to be determined. In contrast to reports in
Tjp2 knockout mice, our TEM analysis of tight junction ultrastruc-
ture revealed no overall increase in tight junction length or
breadth following deletion of Vps33b [4,7]. In future studies,
freeze fracture electron microscopy may be used for a morevol. 66 j 1001–1011 1009
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detailed assessment of tight junction composition in Vps33bfl/fl-
AlfpCre liver.
Analysis of ultrastructural images of Vps33bfl/fl-AlfpCre liver
revealed a significant reduction in apical membrane area due to
a partial loss of canalicular microvilli. This implies a loss of struc-
tural polarity at the apical membrane and an overall reduction of
surface area for movement of solutes from the hepatocyte into
bile. When Rab11a is mutated in mouse intestine, apical brush
border microvilli are lost [43]. These results provide an interest-
ing link between the observed interaction of VPS33B in Rab11a
protein trafficking pathways and the maintenance of apical
microvilli in hepatocytes.
To confirm the role of VPS33B in hepatocyte polarity, we per-
formed in vivo gene rescue studies in Vps33bfl/fl-AlfpCre mice
using ssAAV2/8 vectors containing either wild-type or codon
optimised human VPS33B cDNA (ssAAV2/8-EFS-hVPS33B-WPRE
and ssAAV2/8-EFS-hVPS33Bco-WPRE). At 9 weeks after gene
transfer (1  1012 vg/mouse in 4–5 week old animals) we
observed partial rescue of apical protein localisation, Claudin1
distribution at tight junctions, canalicular ultrastructure and
plasma ALP activity, cholesterol, phospholipid and bile acid
levels. This phenotype correction appeared more robust in ani-
mals treated with the codon optimised vector: all such animals
had plasma total bile acid levels equivalent to those in control
Vps33bfl/fl mice. As well as confirming that the observed loss of
polarity in Vps33bfl/fl-AlfpCre hepatocytes is due to Vps33b muta-
tion, these experiments establish an initial proof of principle for
future therapeutic use of gene transfer in ARC patients. To meet
a therapeutic aim, dose optimisation and safety of VPS33B gene
transfer would need to be determined in future studies.
In conclusion, using our novel Vps33bfl/fl-AlfpCremousemodel,
we have identified that VPS33B is vital for maintenance of mam-
malian structural and functional hepatocyte polarity. We have
established that genetic hepatocyte polarity disorders can be res-
cued using gene transfer with AAV vectors and that ARC liver dis-
ease may be a potential target of therapeutic gene replacement.Financial support
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